HPV testing is an efficient management choice for women with inadequate liquid-based cytology in cervical cancer screening

American Journal of Clinical Pathology

Volumn 138, Issue 1, 2012, Pages 65-71

  Rossi, Paolo Giorgi ^a   Carozzi, Francesca ^b   Collina, Guido ^c   Confortini, Massimo ^b   Dalla Palma, Paolo ^d   De Lillo, Margherita ^e   Del Mistro, Annarosa ^f   Ghiringhello, Bruno ^g   Gillio Tos, Anna ^h   Maioli, Patrizia ⁱ   Pellegrini, Antonella ^j   Schiboni, Maria Luisa ^j   Segnan, Nereo ^k   Zaffina, Leandra M T ^l   Zorzi, Manuel ^m   Ronco, Guglielmo ^k   Mari, D ^k   Giubilato, P ^k   De Marco, L ^h   Ghiringhello, B ^g   Parisio, F ^g   Berardengo, E ⁿ   Andrion, A ^o   Coverlizza, S ^p   Taraglio, S ^q   Accinellli, M G ^h   Polla, E ^r   Pojer, A ^r   Girlando, S ^r   Aldovini, D ^r   Vettorazzi, M ^f   Matteucci, M ^s   Onnis, L ^t   Insacco, E ^t   Minucci, D ^t   Lestani, M ^u   Vignato, A ^v   Manfredi, M ^c   Pierotti, P ^w   Casadei, G P ^w   Collina, G ^x   Schincaglia, P ^y   Serafini, M ^y   Vitali, B ^y   Sintoni, C ⁱ   Aldi, M ⁱ   Folicaldi, S ^z   Nannini, R ^z   Galanti, G ^z   De Lillo, M ^z   Naldoni, C ^aa   Iossa, A ^y   Ciatto, S ^y   Cariaggi, M P ^y   Cecchini, S ^y   Sani, C ^y   Zappa, M ^y   Taddei, G L ^ab   Brezzi, S ^ac   Raggi, P ^ac   Gomes, V ^ac   Pellegrini, A ^j   Schiboni, M L ^j   Chini, F ^ad   Borgia, P ^ad   Cuzick, J ^ae   more..

^a PATHOLOGY UNIT   (Italy)

^b Istituto per lo Studio e la Prevenzione Oncologica   (Italy)

^c Azienda USL di Bologna   (Italy)

^d S Chiara Hospital of Trento   (Italy)

^e AUSL Imola   (Italy)

^f VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^g OIRM S Anna   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ AUSL Ravenna   (Italy)

^j SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^k CPO Piemonte   (Italy)

^l Laziosanità Agency for Public Health Lazio Region   (Italy)

^m Registro Tumori del Veneto   (Italy)

ⁿ Ospedale S Giovanni AS   (Italy)

^o Ospedale Martini   (Italy)

^p S GIOVANNI BOSCO HOSPITAL   (Italy)

^q MARIA VITTORIA HOSPITAL   (Italy)

^r Ospedale di Trento   (Italy)

^s UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^t UNIVERSITY OF PADOVA   (Italy)

^u UNIVERSITY OF VERONA   (Italy)

^v Ospedale di Soave   (Italy)

^w MAGGIORE HOSPITAL   (Italy)

^x BELLARIA HOSPITAL   (Italy)

^y CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^z AUSL di Imola   (Italy)

^aa Regioen Emilia Romagna ^*  (Italy)

^ab UNIVERSITY OF FLORENCE   (Italy)

^ac Local Health Unit   (Italy)

^ad ASP Lazio   (Italy)

^ae QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

Cervical cancer; Cytology; Human papillomavirus; Inadequate; Screening; Triage; Unsatisfactory

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HPV TESTING; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PATIENT REFERRAL; PRIORITY JOURNAL; REPEAT PROCEDURE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CYTODIAGNOSIS; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TRIAGE; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84864252216     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP6J2OEFOYTRFD     Document Type: Article

References (29)

1. Giorgi Rossi P, Baiocchi D, Ciatto S; Endocervical Cells Italian Working Group. Women with a Pap test lacking endocervical cells are at lower risk of CIN2+ than women with negative Pap test with endocervical cells: a cohort study with 4.5 year follow-up. Acta Cytol. 2010;54:265-271.
2. Castle PE, Bulten J, Confortini M, et al. Age-specific patterns of unsatisfactory results for conventional Pap smears and liquid-based cytology: data from two randomised clinical trials. BJOG. 2010; 117:1067-1073.
3. Ronco G, van Ballegooijen M, Becker N, et al. Process performance of cervical screening programmes in Europe. Eur J Cancer. 2009;45:2659-2670.
4. Ronco G, Giubilato P, Naldoni C, et al. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2008 activity. Epidemiol Prev. 2010;34(suppl 4):35-51.
5. Arbyn M, Bergeron C, Klinkhamer P, et al. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol. 2008;111:167-177.
6. Ronco G, Cuzick J, Casadei GP, et al; New Technologies for Cervical Cancer screening (NTCC) Working Group. Accuracy of liquid-based versus conventional cytology: overall results of the New Technologies for Cervical Cancer screening (NTCC) randomised controlled trial. BMJ. 2007;335:28.
7. Colgan TJ, McLachlin CM, Collerchio M, et al. Results of the implementation of liquid-based cytology - SurePath in the Ontario Screening Program. Cancer. 2004;102:362-367. (Pubitemid 39620245)
8. The NHS Information Centre, Public Health Indicators and Population Statistics Team. Cervical Screening Programme England: 2009-10. London, England: The NHS Information Centre; 2010. Available at: http://www.ic.nhs.uk/webfiles/ publications/008-Screening/cervscreen0910/2009-10-Cervical-Bulletin-Final- Report-AI-v1F.pdf. Accessed May 10, 2012.
9. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188:1383-1392.
10. Kulasingam SL, Kim JJ, Lawrence WF, et al ALTS Group. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst. 2006;98:92-100. (Pubitemid 43159963)
11. Ronco G, Cuzick J, Segnan N, et al; and the NTCC Working Group. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer. 2007;43:476-480. (Pubitemid 46177594)
12. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003;188:1393-1400.
13. Sherman ME, Schiffman M, Cox JT; Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS). J Natl Cancer Inst. 2002;94:102-107. (Pubitemid 34121289)
14. Giorgi Rossi P, Chini F, Bisanzi S, et al; the HPV Prevalence Italian Working Group. Distribution of high and low risk HPV types by cytological status: a population based study from Italy. Infect Agent Cancer. 2011;6:2.
15. Kitchener HC, Almonte M, Gilham C, et al ARTISTIC Trial Study Group. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Health Technol Assess. 2009;13:1-150, iii-iv.
16. Ronco G, Giorgi Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing on the subsequent detection of cervical invasive and intraepithelial neoplasia: results from a randomised controlled trial. Lancet Oncol. 2010;11:249-257.
17. Ronco G, Giorgi-Rossi P, Carozzi F, et al; and the NTCC Working Group. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone to conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst. 2008;100:492-501.
18. Ronco G, Segnan N, Giorgi Rossi P, et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the New Technologies for Cervical Cancer Randomized Controlled Trial. J Natl Cancer Inst. 2006;11:765-774. (Pubitemid 43983300)
19. Ronco G, Giorgi-Rossi P, Carozzi F, et al; and the NTCC Working Group. Human papillomavirus testing and liquid-based cytology in primary screening among younger women: results at recruitment from the NTCC randomised controlled trial. Lancet Oncol. 2006;7:547-555. (Pubitemid 43923665)
20. Confortini M, Bergeron C, Desai M, et al New Technologies for Cervical Cancer Screening Study Cytology Group. Accuracy of liquid-based cytology: comparison of the results obtained within a randomized controlled trial (the New Technologies for Cervical Cancer Screening Study) and an external group of experts. Cancer Cytopathol. 2010;118:203-208.
21. Confortini M, Bondi A, Cariaggi MP, et al. Interlaboratory reproducibility of liquid-based equivocal cervical cytology within a randomized controlled trial framework. Diagn Cytopathol. 2007;35:541-544. (Pubitemid 47435615)
22. The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. J Reprod Med. 1992;37:383-386.
23. Carozzi F, Del Mistro A, Confortini M, et al. Reproducibility of HPV DNA testing by Hybrid Capture 2 in a screening setting: intralaboratory and interlaboratory quality control in seven laboratories participating in the same clinical trial. Am J Clin Pathol. 2005;124:1-6.
24. Dalla Palma P, Giorgi Rossi P, Collina G, et al. The reproducibility of CIN diagnoses among different pathologists: data from histology review from a multicentre randomized study. Am J Clin Pathol. 2009;132:125-132.
25. Zhao C, Austin RM. High-risk human papillomavirus DNA test results are useful for disease risk stratification in women with unsatisfactory liquid-based cytology Pap test results. J Low Genit Tract Dis. 2009;13:79-84.
26. Magnani C, Gillio Tos A, De Marco L, et al. Results and cost evaluation of triage with high risk HPV test in cervical cancer screening: a pilot study in Pedmont (NW Italy). Epidemiol Prev. In press.
27. McCaffery KJ, Irwig L, Chan SF, et al. HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice. Patient Educ Couns. 2008;73:473-481.
28. Zhao C, Austin RM. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample. Cancer. 2008;114:242-248.
29. Zhao C, Austin RM. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone. Gynecol Oncol. 2007;107:231-235. (Pubitemid 47575717)